Staphylococcus aureus toxoid multivalent vaccine (Integrated BioTherapeutics)

N/A

Report date: 2024/12/24 16:53:53

Base Information

Drug NameStaphylococcus aureus toxoid multivalent vaccine (Integrated BioTherapeutics)
Drug Alias NameGlycoprotein conjugated S. aureus toxoid vaccineAT-62IBTV-02LBT-SA7IBT-V02
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntegrated Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesIntegrated BiotherapeuticsLimmatech Biologics Ag
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A